earnings

Immunotherapies, biosimilars to dominate next week of earnings
Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Vertex Pharmaceuticals
Sanofi
earnings
Flag link:
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Eli Lilly
earnings
baricitinib
Flag link:
Biogen stock drops 2% after Q1 sales miss
Biogen stock drops 2% after Q1 sales miss
Marketwatch
Biogen
earnings
Flag link:
Big Week Ahead for Eli Lilly: Here's What to Look For
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Eli Lilly
earnings
FDA
Incyte
olumiant
rheumatoid arthritis
Flag link:
What's in the Cards for Glaxo (GSK) This Earnings Season?
What's in the Cards for Glaxo (GSK) This Earnings Season?
Yahoo/Zacks.com
GSK
earnings
Flag link:
3 Drugs That Are Moving the Needle at Johnson & Johnson
3 Drugs That Are Moving the Needle at Johnson & Johnson
Motley Fool
JNJ
Darzalex
Zytiga
Stelara
earnings
Flag link:
Abbott shares down on shrinking Q1 profits
Abbott shares down on shrinking Q1 profits
Mass Device
Abbott Labs
devices
earnings
Flag link:
Intuitive Surgical shares up on Street-beating Q1
Intuitive Surgical shares up on Street-beating Q1
Mass Device
earnings
Intuitive Surgical
devices
Flag link:
Johnson & Johnson tops 1Q views on sales spike, but net dips
Johnson & Johnson tops 1Q views on sales spike, but net dips
Yahoo/AP
JNJ
earnings
Flag link:
Johnson & Johnson (JNJ) Expected to Announce Quarterly Sales of $19.38 Billion
Johnson & Johnson (JNJ) Expected to Announce Quarterly Sales of $19.38 Billion
Daily Political
JNJ
earnings
Flag link:
Q1 kicks off with J&J, Novartis, Glaxo results
Q1 kicks off with J&J, Novartis, Glaxo results
Biopharma Dive
earnings
JNJ
Novartis
GSK
Flag link:
Why Tandem Diabetes Care Is Soaring 18.5% Higher Today
Why Tandem Diabetes Care Is Soaring 18.5% Higher Today
Motley Fool
earnings
Tandem Diabetes
devices
Flag link:
The five causes for Bayer’s disappointing Q4 results
The five causes for Bayer’s disappointing Q4 results
GoinPharma
Bayer
earnings
Flag link:
Why Puma Biotechnology Shares Jumped 15% Friday
Why Puma Biotechnology Shares Jumped 15% Friday
Motley Fool
Puma Biotechnology
earnings
Nerlynx
breast cancer
Flag link:
5 Ways Valeant Pharmaceutical Plans to Turn Things Around
5 Ways Valeant Pharmaceutical Plans to Turn Things Around
Motley Fool
Valeant Pharmaceuticals
earnings
Ortho Dermatologics
debt
operational efficiency
R&D
Flag link:
Mylan: Generic competition pushes EpiPen sales down
Mylan: Generic competition pushes EpiPen sales down
Drug Delivery Business News
Mylan Labs
earnings
generics
EpiPens
Flag link:
Valeant shares slump even as drugmaker posts highest net profit in three years
Valeant shares slump even as drugmaker posts highest net profit in three years
Financial Post
Valeant Pharmaceuticals
earnings
Flag link:
Turns out, Bayer HealthCare's faltering even before Monsanto enters the fold
Turns out, Bayer HealthCare's faltering even before Monsanto enters the fold
Fierce Pharma
Bayer Healthcare
Monsanto
earnings
Flag link:
3 Bright Spots in MannKind Corporation's Q4 Update
3 Bright Spots in MannKind Corporation's Q4 Update
Motley Fool
MannKind
earnings
Flag link:
Here's Why Depomed Inc Fell as Much as 13.8% Today
Here's Why Depomed Inc Fell as Much as 13.8% Today
Motley Fool
Depomed
earnings
Flag link:

Pages